Please login to the form below

Not currently logged in
Email:
Password:

Wellcome Trust

This page shows the latest Wellcome Trust news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Karuna raises $42m for novel CNS approach, Chen exits Roche, Orchard gains GSK board member

Daily Brief: Karuna raises $42m for novel CNS approach, Chen exits Roche, Orchard gains GSK board member

Participants included ARCH Venture Partners, the Wellcome Trust, Steven Paul MD, PureTech Health, and other undisclosed investors.

Latest news

More from news
Approximately 2 fully matching, plus 59 partially matching documents found.

Latest Intelligence

  • Rules of engagement Rules of engagement

    A similar study of people in the United Kingdom, published in the same year by the UK biomedical charity the Wellcome Trust, revealed comparable trends.  In order to develop a meaningful ... trust and maintaining customer relationships. The question

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    Lord Jim O’Neill’s Report on AMR two years ago, supported by the UK Government and the Wellcome Trust, was an important catalyst for action.

  • The real-world data conundrum The real-world data conundrum

    The window of opportunity is open. Public trust is considered by many to be the biggest challenge for the commercial sector. ... However, a comprehensive study (by Ipsos Mori and the Wellcome Trust in 2016) has shown that most of the general public tend

  • Pharma deals during January 2015 Pharma deals during January 2015

    In a similar vein, other off the top 20 table deal activity of note was the announcement by AstraZeneca of four academic collaborations (Wellcome Trust, Innovative Genomics Institute, Thermo Fisher Scientific

  • Pharma deals during August 2013 Pharma deals during August 2013

    Leuven and the Wellcome Trust.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Zyme Communications strengthens team Zyme Communications strengthens team

    Prior to Zyme, Ricketts served Axol Bioscience as its science marketing specialist and content writer and has previously worked as a research at the Institute of Cancer Research and Wellcome Trust

  • EM Imaging appoints new chairman EM Imaging appoints new chairman

    Jeans also chairs the board of UK Biocentre, and has sat on advisory panels for the MRC, EPSRC, NIHR and the Wellcome Trust. .

  • Bioinformatics firm Eagle adds to senior team Bioinformatics firm Eagle adds to senior team

    Spooner, who has previously served at the likes of the Wellcome Trust Sanger Institute and the European Bioinformatics Institute, will be responsible for ensuring that Eagle remains "at the forefront of

  • Three directors join UK’s MHRA Three directors join UK’s MHRA

    His research has focused on internal medicine, hypertension and cardiovascular risk management, and he established Edinburgh University's Wellcome Trust cardiovascular research initiative and centre for cardiovascular science. ... In addition to his

  • Edward Hodgkin elected chair of UK biotech association Edward Hodgkin elected chair of UK biotech association

    Hodgkin is currently a partner at the Wellcome Trust's independent subsidiary Syncona Partners, where his role is to create and lead new life science ventures.

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics